Thomas James Gunderson - May 27, 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
/s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 05:27 PM
Next filing
Jun 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +13.5K $0.00 13.5K May 27, 2021 Common Stock 13.5K $26.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of the first anniversary of the date of grant, May 27, 2022, or the date of the following annual meeting of shareholders of the Company.